Immunotherapy with Anti-CD3 x Anti-CMV bispecific antibody (CMVBi) armed donor derived activated T cells (ATC) - a novel strategy against cytomegalovirus (CMV) post allogeneic stem cell transplantation (SCT)
Year: 2010
Type: article
Source: F1000Research
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1452327051